Antonius A. Miller

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Rogério Lilenbaum, James E. Herndon, Marcy A. List et al. · Journal of Clinical Oncology · 2004 · 451 citations

Medicine, Oncology, Pharmacology +14

Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431

Everett E. Vokes, James E. Herndon, Jeffrey Crawford et al. · Journal of Clinical Oncology · 2002 · 374 citations

Medicine, Oncology, Pharmacology +14

Clinical pharmacology of sodium butyrate in patients with acute leukemia

Antonius A. Miller, E. Kurschel, R. Osieka et al. · European Journal of Cancer and Clinical Oncology · 1987 · 251 citations

Medicine, Pharmacokinetics, Pharmacology +12

Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301

Antonius A. Miller, Daryl J. Murry, Kouros Owzar et al. · Journal of Clinical Oncology · 2009 · 207 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732

Harvey B. Niell, James E. Herndon, Antonius A. Miller et al. · Journal of Clinical Oncology · 2005 · 188 citations

Medicine, Oncology, Pharmacology +11